These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11730650)

  • 1. Predictive value of a 1-day, 1-eye trial on the 1-month ocular hypotensive response of latanoprost 0.005%.
    Mansberger SL; Passo MS; Schalock PI; Cioffi GA
    Am J Ophthalmol; 2001 Dec; 132(6):869-71. PubMed ID: 11730650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.
    Netland PA; Landry T; Sullivan EK; Andrew R; Silver L; Weiner A; Mallick S; Dickerson J; Bergamini MV; Robertson SM; Davis AA;
    Am J Ophthalmol; 2001 Oct; 132(4):472-84. PubMed ID: 11589866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension.
    Aung T; Chew PT; Yip CC; Chan YH; See JL; Khng CG; Hoh ST; Ng LH; Lee HM
    Am J Ophthalmol; 2001 May; 131(5):636-42. PubMed ID: 11336940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.
    Noecker RS; Dirks MS; Choplin NT; Bernstein P; Batoosingh AL; Whitcup SM;
    Am J Ophthalmol; 2003 Jan; 135(1):55-63. PubMed ID: 12504698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucoma.
    Sponsel WE; Paris G; Trigo Y; Pena M
    Am J Ophthalmol; 2002 Oct; 134(4):552-9. PubMed ID: 12383812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latanoprost and brimonidine: therapeutic and physiologic assessment before and after oral nonsteroidal anti-inflammatory therapy.
    Sponsel WE; Paris G; Trigo Y; Pena M; Weber A; Sanford K; McKinnon S
    Am J Ophthalmol; 2002 Jan; 133(1):11-8. PubMed ID: 11755835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of a 1-day, 1-eye trial on the 1-month ocular hypotensive response of latanoprost 0.005%.
    Freigassner PS
    Am J Ophthalmol; 2002 Jul; 134(1):150; author reply 150. PubMed ID: 12095836
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized clinical trial of latanoprost and unoprostone in patients with elevated intraocular pressure.
    Jampel HD; Bacharach J; Sheu WP; Wohl LG; Solish AM; Christie W;
    Am J Ophthalmol; 2002 Dec; 134(6):863-71. PubMed ID: 12470755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.
    Walters TR; DuBiner HB; Carpenter SP; Khan B; VanDenburgh AM;
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S26-35. PubMed ID: 15016559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
    Maruyama K; Shirato S
    J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of latanoprost is independent of the width of the ciliary body face.
    Ritch R; Ishikawa H; Rothman R; Yu G; Liebmann JM
    J Glaucoma; 2002 Jun; 11(3):239-43. PubMed ID: 12140402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of latanoprost and unoprostone when used alone or in combination for open-angle glaucoma.
    Saito M; Takano R; Shirato S
    Am J Ophthalmol; 2001 Oct; 132(4):485-9. PubMed ID: 11589867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of latanoprost on intraocular pressure in steroid-induced glaucoma.
    Scherer WJ; Hauber FA
    J Glaucoma; 2000 Apr; 9(2):179-82. PubMed ID: 10782629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive intraocular pressure reduction effect of fixed combination of maleate timolol 0.5%/dorzolamide 2% (Cosopt) on monotherapy with latanoprost (Xalatan) in patients with elevated intraocular pressure: a prospective, 4-week, open-label, randomized, controlled clinical trial.
    Hatanaka M; Reis A; Sano ME; Susanna R
    J Glaucoma; 2010; 19(5):331-5. PubMed ID: 19730119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
    Tamer C; Oksüz H
    Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial.
    Garway-Heath DF; Crabb DP; Bunce C; Lascaratos G; Amalfitano F; Anand N; Azuara-Blanco A; Bourne RR; Broadway DC; Cunliffe IA; Diamond JP; Fraser SG; Ho TA; Martin KR; McNaught AI; Negi A; Patel K; Russell RA; Shah A; Spry PG; Suzuki K; White ET; Wormald RP; Xing W; Zeyen TG
    Lancet; 2015 Apr; 385(9975):1295-304. PubMed ID: 25533656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraocular pressure after replacement of current dual therapy with latanoprost monotherapy in patients with open angle glaucoma.
    Pillunat LE; Larsson LI;
    Br J Ophthalmol; 2003 Dec; 87(12):1492-6. PubMed ID: 14660460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latanoprost for uncontrolled glaucoma in a compassionate case protocol.
    Patelska B; Greenfield DS; Liebmann JM; Wand M; Kushnick H; Ritch R
    Am J Ophthalmol; 1997 Sep; 124(3):279-86. PubMed ID: 9439353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular hypotensive effects and safety over 3 months of switching from an unfixed combination to latanoprost 0.005%/timolol maleate 0.5% fixed combination.
    Inoue K; Okayama R; Higa R; Sawada H; Wakakura M; Tomita G
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):581-7. PubMed ID: 22011049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma.
    Konstas AG; Maltezos AC; Gandi S; Hudgins AC; Stewart WC
    Am J Ophthalmol; 1999 Jul; 128(1):15-20. PubMed ID: 10482089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.